Drug_Interaction_ID,Drug_1_Name,Drug_1_RxCUI,Drug_1_Class_Name,Drug_1_Code,Drug_2_Name,Drug_2_RxCUI,Drug_2_Class_Name,Drug_2_Code,Clinical_Source,Source_File,Description,Severity,Comment,Drug_Name,RxNorm,Source_File,Clinical_Source,Class_Name,Class_Code,Drug_Name,RxNorm,Source_File,Clinical_Source,Class_Name,Class_Code
1183,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",CITALOPRAM,2556,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1183,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",ESCITALOPRAM,321988,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1183,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",FLUOXETINE,4493,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1183,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",FLUVOXAMINE,42355,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1183,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",PAROXETINE,32937,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1183,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",SERTRALINE,36437,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1183,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",VORTIOXETINE,1455099,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",CITALOPRAM,2556,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,AMITRIPTYLINE,704,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",ESCITALOPRAM,321988,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,AMITRIPTYLINE,704,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",FLUOXETINE,4493,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,AMITRIPTYLINE,704,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",FLUVOXAMINE,42355,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,AMITRIPTYLINE,704,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",PAROXETINE,32937,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,AMITRIPTYLINE,704,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",SERTRALINE,36437,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,AMITRIPTYLINE,704,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",VORTIOXETINE,1455099,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,AMITRIPTYLINE,704,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",CITALOPRAM,2556,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,AMOXAPINE,722,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",ESCITALOPRAM,321988,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,AMOXAPINE,722,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",FLUOXETINE,4493,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,AMOXAPINE,722,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",FLUVOXAMINE,42355,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,AMOXAPINE,722,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",PAROXETINE,32937,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,AMOXAPINE,722,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",SERTRALINE,36437,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,AMOXAPINE,722,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",VORTIOXETINE,1455099,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,AMOXAPINE,722,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,AMOXAPINE,722,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,AMITRIPTYLINE,704,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,"CHLORPROMAZINE ",2403,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,AMITRIPTYLINE,704,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,CLOMIPRAMINE,2597,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,AMITRIPTYLINE,704,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,"CLOZAPINE ",2626,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,AMITRIPTYLINE,704,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,DOXEPIN,3638,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,AMITRIPTYLINE,704,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,FLUPHENAZINE,4496,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,AMITRIPTYLINE,704,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,IMIPRAMINE,5691,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,AMITRIPTYLINE,704,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,LOXAPINE,6475,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,AMITRIPTYLINE,704,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,MAPROTILINE,6646,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,AMITRIPTYLINE,704,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,QUETIAPINE,51272,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,AMITRIPTYLINE,704,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,TRIMIPRAMINE,10834,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,AMITRIPTYLINE,704,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,AMITRIPTYLINE,704,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,AMOXAPINE,722,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,"CHLORPROMAZINE ",2403,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,AMOXAPINE,722,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,CLOMIPRAMINE,2597,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,AMOXAPINE,722,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,"CLOZAPINE ",2626,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,AMOXAPINE,722,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,DOXEPIN,3638,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,AMOXAPINE,722,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,FLUPHENAZINE,4496,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,AMOXAPINE,722,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,IMIPRAMINE,5691,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,AMOXAPINE,722,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,LOXAPINE,6475,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,AMOXAPINE,722,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,MAPROTILINE,6646,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,AMOXAPINE,722,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,QUETIAPINE,51272,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,AMOXAPINE,722,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,TRIMIPRAMINE,10834,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,AMOXAPINE,722,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,AMITRIPTYLINE,704,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,"CHLORPROMAZINE ",2403,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,AMOXAPINE,722,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,"CHLORPROMAZINE ",2403,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,CLOMIPRAMINE,2597,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,"CHLORPROMAZINE ",2403,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,"CLOZAPINE ",2626,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,"CHLORPROMAZINE ",2403,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,DOXEPIN,3638,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,"CHLORPROMAZINE ",2403,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,FLUPHENAZINE,4496,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,"CHLORPROMAZINE ",2403,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,IMIPRAMINE,5691,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,"CHLORPROMAZINE ",2403,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,LOXAPINE,6475,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,"CHLORPROMAZINE ",2403,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,MAPROTILINE,6646,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,"CHLORPROMAZINE ",2403,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1439,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,336-MIXED-ADRENERGIC-SEROTONINERGIC-MEDICATIONS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after it is stopped.",AMITRIPTYLINE,704,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1439,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,336-MIXED-ADRENERGIC-SEROTONINERGIC-MEDICATIONS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after it is stopped.",CLOMIPRAMINE,2597,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1439,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,336-MIXED-ADRENERGIC-SEROTONINERGIC-MEDICATIONS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after it is stopped.",DULOXETINE,72625,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1439,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,336-MIXED-ADRENERGIC-SEROTONINERGIC-MEDICATIONS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after it is stopped.",IMIPRAMINE,5691,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1439,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,336-MIXED-ADRENERGIC-SEROTONINERGIC-MEDICATIONS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after it is stopped.",MILNACIPRAN,588250,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1439,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,336-MIXED-ADRENERGIC-SEROTONINERGIC-MEDICATIONS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after it is stopped.",VENLAFAXINE,39786,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
2410,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"OTHER ORAL ANTICOAGULANTS",B01A-001,ANSM,52-ORAL-ANTICOAGULANTS.html,"Risk of increase of hemorrhagic events when one oral anticoagulant is replaced with another.","Take into account","Take into account the half-life of the oral anticoagulant and observe, if the situation requires, a delay for clearance before the start of treatment with another. Be sure to inform the patient.",RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
2410,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"OTHER ORAL ANTICOAGULANTS",B01A-001,ANSM,52-ORAL-ANTICOAGULANTS.html,"Risk of increase of hemorrhagic events when one oral anticoagulant is replaced with another.","Take into account","Take into account the half-life of the oral anticoagulant and observe, if the situation requires, a delay for clearance before the start of treatment with another. Be sure to inform the patient.",WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
2419,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hermorrhage.","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after they are stopped.",APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,AMITRIPTYLINE,704,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A
2419,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hermorrhage.","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after they are stopped.",RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,AMITRIPTYLINE,704,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A
2419,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hermorrhage.","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after they are stopped.",WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,AMITRIPTYLINE,704,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A
2783,,NULL,"VITAMIN K ANTAGONISTS",B01AA-001,,NULL,"HMG-COA REDUCTASE INHIBITORS (STATINS)",C10AA,ANSM,73-VITAMIN-K-ANTAGONISTS.html,"Increase of the effect of the Vitamin K antagonist and of the risk of hemorrhage","Precaution for use","More frequent testing of the INR. Possible adjustment of the dosage of the Vitamin K antagonist.",WARFARIN,11289,160,ANSM,"VITAMIN K ANTAGONISTS",B01AA-001,ATORVASTATIN,83367,69,ANSM,"HMG-COA REDUCTASE INHIBITORS (STATINS)",C10AA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,ESCITALOPRAM,321988,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,CITALOPRAM,2556,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,FLUOXETINE,4493,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,CITALOPRAM,2556,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,FLUVOXAMINE,42355,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,CITALOPRAM,2556,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,PAROXETINE,32937,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,CITALOPRAM,2556,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,SERTRALINE,36437,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,CITALOPRAM,2556,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",CITALOPRAM,2556,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,CLOMIPRAMINE,2597,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",ESCITALOPRAM,321988,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,CLOMIPRAMINE,2597,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",FLUOXETINE,4493,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,CLOMIPRAMINE,2597,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",FLUVOXAMINE,42355,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,CLOMIPRAMINE,2597,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,QUETIAPINE,51272,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,"CHLORPROMAZINE ",2403,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,TRIMIPRAMINE,10834,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,"CHLORPROMAZINE ",2403,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,AMITRIPTYLINE,704,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,CLOMIPRAMINE,2597,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,AMOXAPINE,722,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,CLOMIPRAMINE,2597,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,"CHLORPROMAZINE ",2403,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,CLOMIPRAMINE,2597,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,"CLOZAPINE ",2626,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,CLOMIPRAMINE,2597,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,DOXEPIN,3638,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,CLOMIPRAMINE,2597,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,FLUPHENAZINE,4496,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,CLOMIPRAMINE,2597,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,IMIPRAMINE,5691,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,CLOMIPRAMINE,2597,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,LOXAPINE,6475,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,CLOMIPRAMINE,2597,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,MAPROTILINE,6646,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,CLOMIPRAMINE,2597,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,QUETIAPINE,51272,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,CLOMIPRAMINE,2597,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,TRIMIPRAMINE,10834,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,CLOMIPRAMINE,2597,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1640,,NULL,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,ANSM,377-NEUROLEPTICS-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"-with citalopram, domperidone, escitalopram, hydroxyzine and piperaquine",FLUPHENAZINE,4496,101,ANSM,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,"CHLORPROMAZINE ",2403,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05
1640,,NULL,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,ANSM,377-NEUROLEPTICS-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"-with citalopram, domperidone, escitalopram, hydroxyzine and piperaquine",HALOPERIDOL,5093,101,ANSM,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,"CHLORPROMAZINE ",2403,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05
1640,,NULL,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,ANSM,377-NEUROLEPTICS-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"-with citalopram, domperidone, escitalopram, hydroxyzine and piperaquine","CHLORPROMAZINE ",2403,101,ANSM,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,CITALOPRAM,2556,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05
1640,,NULL,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,ANSM,377-NEUROLEPTICS-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"-with citalopram, domperidone, escitalopram, hydroxyzine and piperaquine",FLUPHENAZINE,4496,101,ANSM,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,CITALOPRAM,2556,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05
1640,,NULL,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,ANSM,377-NEUROLEPTICS-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"-with citalopram, domperidone, escitalopram, hydroxyzine and piperaquine",HALOPERIDOL,5093,101,ANSM,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,CITALOPRAM,2556,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05
2208,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,,NULL,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,ANSM,484-SUBSTANCES-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--with citalopram, dromperidone, escitalopram, hydroxyzine, piperaquine",CITALOPRAM,2556,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,"CHLORPROMAZINE ",2403,101,ANSM,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002
2208,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,,NULL,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,ANSM,484-SUBSTANCES-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--with citalopram, dromperidone, escitalopram, hydroxyzine, piperaquine",ESCITALOPRAM,321988,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,"CHLORPROMAZINE ",2403,101,ANSM,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002
2208,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,,NULL,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,ANSM,484-SUBSTANCES-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--with citalopram, dromperidone, escitalopram, hydroxyzine, piperaquine",FLUPHENAZINE,4496,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,"CHLORPROMAZINE ",2403,101,ANSM,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002
2208,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,,NULL,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,ANSM,484-SUBSTANCES-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--with citalopram, dromperidone, escitalopram, hydroxyzine, piperaquine",HALOPERIDOL,5093,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,"CHLORPROMAZINE ",2403,101,ANSM,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002
2212,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,,NULL,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B,ANSM,484-SUBSTANCES-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--For dolasetron, erythromycin, spiramycin and vicamine, only the forms administerd by IV route are concerned by this interaction","CHLORPROMAZINE ",2403,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,CITALOPRAM,2556,144,ANSM,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B
2212,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,,NULL,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B,ANSM,484-SUBSTANCES-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--For dolasetron, erythromycin, spiramycin and vicamine, only the forms administerd by IV route are concerned by this interaction",ESCITALOPRAM,321988,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,CITALOPRAM,2556,144,ANSM,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B
2212,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,,NULL,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B,ANSM,484-SUBSTANCES-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--For dolasetron, erythromycin, spiramycin and vicamine, only the forms administerd by IV route are concerned by this interaction",FLUPHENAZINE,4496,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,CITALOPRAM,2556,144,ANSM,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B
2212,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,,NULL,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B,ANSM,484-SUBSTANCES-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--For dolasetron, erythromycin, spiramycin and vicamine, only the forms administerd by IV route are concerned by this interaction",HALOPERIDOL,5093,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,CITALOPRAM,2556,144,ANSM,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B
2417,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,CITALOPRAM,2556,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2417,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,CITALOPRAM,2556,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2417,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,CITALOPRAM,2556,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2419,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hermorrhage.","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after they are stopped.",APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,CLOMIPRAMINE,2597,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A
2419,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hermorrhage.","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after they are stopped.",RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,CLOMIPRAMINE,2597,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A
2419,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hermorrhage.","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after they are stopped.",WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,CLOMIPRAMINE,2597,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A
2441,,NULL,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,ANSM,"524-TORSADES-DE-POINTES-INDUCING-MEDICATIONS-(EXCEPT-ANTIPARASITICS,-NEUROLEPTICS,-METHADONE).html","Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--for dolasetron, erythromycin, spiramycin, and vincamine, only the forms administered by IV route are affected by this interaction.",CITALOPRAM,2556,144,ANSM,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B,"CHLORPROMAZINE ",2403,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05
2441,,NULL,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,ANSM,"524-TORSADES-DE-POINTES-INDUCING-MEDICATIONS-(EXCEPT-ANTIPARASITICS,-NEUROLEPTICS,-METHADONE).html","Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--for dolasetron, erythromycin, spiramycin, and vincamine, only the forms administered by IV route are affected by this interaction.",ESCITALOPRAM,321988,144,ANSM,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B,"CHLORPROMAZINE ",2403,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05
2441,,NULL,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,ANSM,"524-TORSADES-DE-POINTES-INDUCING-MEDICATIONS-(EXCEPT-ANTIPARASITICS,-NEUROLEPTICS,-METHADONE).html","Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--for dolasetron, erythromycin, spiramycin, and vincamine, only the forms administered by IV route are affected by this interaction.",ESCITALOPRAM,321988,144,ANSM,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B,CITALOPRAM,2556,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",AMITRIPTYLINE,704,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,CITALOPRAM,2556,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",AMOXAPINE,722,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,CITALOPRAM,2556,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",CLOMIPRAMINE,2597,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,CITALOPRAM,2556,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",DOXEPIN,3638,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,CITALOPRAM,2556,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",IMIPRAMINE,5691,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,CITALOPRAM,2556,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",MAPROTILINE,6646,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,CITALOPRAM,2556,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",TRIMIPRAMINE,10834,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,CITALOPRAM,2556,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
876,,NULL,HYPNOTICS,N05-R06,,NULL,"OTHER HYPNOTICS",N05-R06,ANSM,272-HYPNOTICS.html,"Increase of central nervous system depression","Take into account",,ZOLPIDEM,39993,71,ANSM,HYPNOTICS,N05-R06,ESTAZOLAM,4077,71,ANSM,HYPNOTICS,N05-R06
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,CITALOPRAM,2556,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,ESCITALOPRAM,321988,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,FLUOXETINE,4493,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,ESCITALOPRAM,321988,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,FLUVOXAMINE,42355,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,ESCITALOPRAM,321988,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,PAROXETINE,32937,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,ESCITALOPRAM,321988,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,SERTRALINE,36437,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,ESCITALOPRAM,321988,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",PAROXETINE,32937,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,CLOMIPRAMINE,2597,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",SERTRALINE,36437,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,CLOMIPRAMINE,2597,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",VORTIOXETINE,1455099,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,CLOMIPRAMINE,2597,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",CITALOPRAM,2556,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,DOXEPIN,3638,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",ESCITALOPRAM,321988,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,DOXEPIN,3638,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",FLUOXETINE,4493,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,DOXEPIN,3638,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",FLUVOXAMINE,42355,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,DOXEPIN,3638,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",PAROXETINE,32937,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,DOXEPIN,3638,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",SERTRALINE,36437,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,DOXEPIN,3638,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",VORTIOXETINE,1455099,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,DOXEPIN,3638,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,AMITRIPTYLINE,704,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,"CLOZAPINE ",2626,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,AMOXAPINE,722,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,"CLOZAPINE ",2626,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,"CHLORPROMAZINE ",2403,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,"CLOZAPINE ",2626,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,CLOMIPRAMINE,2597,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,"CLOZAPINE ",2626,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,DOXEPIN,3638,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,"CLOZAPINE ",2626,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,FLUPHENAZINE,4496,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,"CLOZAPINE ",2626,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,IMIPRAMINE,5691,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,"CLOZAPINE ",2626,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,LOXAPINE,6475,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,"CLOZAPINE ",2626,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,MAPROTILINE,6646,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,"CLOZAPINE ",2626,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,QUETIAPINE,51272,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,"CLOZAPINE ",2626,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,TRIMIPRAMINE,10834,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,"CLOZAPINE ",2626,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,AMITRIPTYLINE,704,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,DOXEPIN,3638,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,AMOXAPINE,722,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,DOXEPIN,3638,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,"CHLORPROMAZINE ",2403,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,DOXEPIN,3638,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,CLOMIPRAMINE,2597,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,DOXEPIN,3638,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,"CLOZAPINE ",2626,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,DOXEPIN,3638,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,FLUPHENAZINE,4496,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,DOXEPIN,3638,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,IMIPRAMINE,5691,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,DOXEPIN,3638,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,LOXAPINE,6475,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,DOXEPIN,3638,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,MAPROTILINE,6646,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,DOXEPIN,3638,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,QUETIAPINE,51272,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,DOXEPIN,3638,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,TRIMIPRAMINE,10834,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,DOXEPIN,3638,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1640,,NULL,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,ANSM,377-NEUROLEPTICS-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"-with citalopram, domperidone, escitalopram, hydroxyzine and piperaquine","CHLORPROMAZINE ",2403,101,ANSM,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,ESCITALOPRAM,321988,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05
1640,,NULL,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,ANSM,377-NEUROLEPTICS-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"-with citalopram, domperidone, escitalopram, hydroxyzine and piperaquine",FLUPHENAZINE,4496,101,ANSM,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,ESCITALOPRAM,321988,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05
1640,,NULL,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,ANSM,377-NEUROLEPTICS-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"-with citalopram, domperidone, escitalopram, hydroxyzine and piperaquine",HALOPERIDOL,5093,101,ANSM,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,ESCITALOPRAM,321988,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05
2212,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,,NULL,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B,ANSM,484-SUBSTANCES-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--For dolasetron, erythromycin, spiramycin and vicamine, only the forms administerd by IV route are concerned by this interaction","CHLORPROMAZINE ",2403,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,ESCITALOPRAM,321988,144,ANSM,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B
2212,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,,NULL,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B,ANSM,484-SUBSTANCES-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--For dolasetron, erythromycin, spiramycin and vicamine, only the forms administerd by IV route are concerned by this interaction",CITALOPRAM,2556,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,ESCITALOPRAM,321988,144,ANSM,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B
2212,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,,NULL,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B,ANSM,484-SUBSTANCES-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--For dolasetron, erythromycin, spiramycin and vicamine, only the forms administerd by IV route are concerned by this interaction",FLUPHENAZINE,4496,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,ESCITALOPRAM,321988,144,ANSM,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B
2212,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,,NULL,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B,ANSM,484-SUBSTANCES-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--For dolasetron, erythromycin, spiramycin and vicamine, only the forms administerd by IV route are concerned by this interaction",HALOPERIDOL,5093,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,ESCITALOPRAM,321988,144,ANSM,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B
2417,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,ESCITALOPRAM,321988,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2417,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,ESCITALOPRAM,321988,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2417,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,ESCITALOPRAM,321988,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2419,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hermorrhage.","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after they are stopped.",APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,DULOXETINE,72625,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A
2419,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hermorrhage.","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after they are stopped.",RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,DULOXETINE,72625,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A
2419,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hermorrhage.","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after they are stopped.",WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,DULOXETINE,72625,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A
2441,,NULL,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,ANSM,"524-TORSADES-DE-POINTES-INDUCING-MEDICATIONS-(EXCEPT-ANTIPARASITICS,-NEUROLEPTICS,-METHADONE).html","Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--for dolasetron, erythromycin, spiramycin, and vincamine, only the forms administered by IV route are affected by this interaction.",CITALOPRAM,2556,144,ANSM,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B,ESCITALOPRAM,321988,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",AMITRIPTYLINE,704,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ESCITALOPRAM,321988,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",AMOXAPINE,722,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ESCITALOPRAM,321988,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",CLOMIPRAMINE,2597,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ESCITALOPRAM,321988,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",DOXEPIN,3638,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ESCITALOPRAM,321988,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",IMIPRAMINE,5691,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ESCITALOPRAM,321988,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",MAPROTILINE,6646,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ESCITALOPRAM,321988,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",TRIMIPRAMINE,10834,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ESCITALOPRAM,321988,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,CITALOPRAM,2556,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,FLUOXETINE,4493,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,ESCITALOPRAM,321988,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,FLUOXETINE,4493,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,FLUVOXAMINE,42355,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,FLUOXETINE,4493,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,PAROXETINE,32937,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,FLUOXETINE,4493,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,SERTRALINE,36437,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,FLUOXETINE,4493,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,CITALOPRAM,2556,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,FLUVOXAMINE,42355,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,ESCITALOPRAM,321988,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,FLUVOXAMINE,42355,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,FLUOXETINE,4493,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,FLUVOXAMINE,42355,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,PAROXETINE,32937,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,FLUVOXAMINE,42355,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,SERTRALINE,36437,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,FLUVOXAMINE,42355,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,AMITRIPTYLINE,704,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,FLUPHENAZINE,4496,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,AMOXAPINE,722,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,FLUPHENAZINE,4496,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,"CHLORPROMAZINE ",2403,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,FLUPHENAZINE,4496,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,CLOMIPRAMINE,2597,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,FLUPHENAZINE,4496,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,"CLOZAPINE ",2626,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,FLUPHENAZINE,4496,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,DOXEPIN,3638,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,FLUPHENAZINE,4496,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,IMIPRAMINE,5691,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,FLUPHENAZINE,4496,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,LOXAPINE,6475,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,FLUPHENAZINE,4496,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,MAPROTILINE,6646,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,FLUPHENAZINE,4496,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,QUETIAPINE,51272,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,FLUPHENAZINE,4496,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,TRIMIPRAMINE,10834,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,FLUPHENAZINE,4496,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1640,,NULL,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,ANSM,377-NEUROLEPTICS-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"-with citalopram, domperidone, escitalopram, hydroxyzine and piperaquine","CHLORPROMAZINE ",2403,101,ANSM,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,FLUPHENAZINE,4496,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05
1640,,NULL,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,ANSM,377-NEUROLEPTICS-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"-with citalopram, domperidone, escitalopram, hydroxyzine and piperaquine",HALOPERIDOL,5093,101,ANSM,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,FLUPHENAZINE,4496,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05
2208,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,,NULL,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,ANSM,484-SUBSTANCES-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--with citalopram, dromperidone, escitalopram, hydroxyzine, piperaquine","CHLORPROMAZINE ",2403,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,FLUPHENAZINE,4496,101,ANSM,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002
2208,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,,NULL,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,ANSM,484-SUBSTANCES-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--with citalopram, dromperidone, escitalopram, hydroxyzine, piperaquine",CITALOPRAM,2556,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,FLUPHENAZINE,4496,101,ANSM,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002
2208,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,,NULL,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,ANSM,484-SUBSTANCES-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--with citalopram, dromperidone, escitalopram, hydroxyzine, piperaquine",ESCITALOPRAM,321988,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,FLUPHENAZINE,4496,101,ANSM,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002
2208,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,,NULL,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,ANSM,484-SUBSTANCES-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--with citalopram, dromperidone, escitalopram, hydroxyzine, piperaquine",HALOPERIDOL,5093,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,FLUPHENAZINE,4496,101,ANSM,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002
2417,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,FLUOXETINE,4493,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2417,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,FLUOXETINE,4493,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2417,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,FLUOXETINE,4493,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2417,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,FLUVOXAMINE,42355,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2417,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,FLUVOXAMINE,42355,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2417,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,FLUVOXAMINE,42355,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2441,,NULL,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,ANSM,"524-TORSADES-DE-POINTES-INDUCING-MEDICATIONS-(EXCEPT-ANTIPARASITICS,-NEUROLEPTICS,-METHADONE).html","Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--for dolasetron, erythromycin, spiramycin, and vincamine, only the forms administered by IV route are affected by this interaction.",CITALOPRAM,2556,144,ANSM,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B,FLUPHENAZINE,4496,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05
2441,,NULL,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,ANSM,"524-TORSADES-DE-POINTES-INDUCING-MEDICATIONS-(EXCEPT-ANTIPARASITICS,-NEUROLEPTICS,-METHADONE).html","Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--for dolasetron, erythromycin, spiramycin, and vincamine, only the forms administered by IV route are affected by this interaction.",ESCITALOPRAM,321988,144,ANSM,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B,FLUPHENAZINE,4496,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",AMITRIPTYLINE,704,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,FLUOXETINE,4493,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",AMOXAPINE,722,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,FLUOXETINE,4493,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",CLOMIPRAMINE,2597,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,FLUOXETINE,4493,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",DOXEPIN,3638,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,FLUOXETINE,4493,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",IMIPRAMINE,5691,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,FLUOXETINE,4493,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",MAPROTILINE,6646,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,FLUOXETINE,4493,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",TRIMIPRAMINE,10834,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,FLUOXETINE,4493,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",AMITRIPTYLINE,704,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,FLUVOXAMINE,42355,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",AMOXAPINE,722,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,FLUVOXAMINE,42355,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",CLOMIPRAMINE,2597,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,FLUVOXAMINE,42355,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",DOXEPIN,3638,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,FLUVOXAMINE,42355,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",IMIPRAMINE,5691,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,FLUVOXAMINE,42355,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",MAPROTILINE,6646,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,FLUVOXAMINE,42355,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",TRIMIPRAMINE,10834,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,FLUVOXAMINE,42355,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2783,,NULL,"VITAMIN K ANTAGONISTS",B01AA-001,,NULL,"HMG-COA REDUCTASE INHIBITORS (STATINS)",C10AA,ANSM,73-VITAMIN-K-ANTAGONISTS.html,"Increase of the effect of the Vitamin K antagonist and of the risk of hemorrhage","Precaution for use","More frequent testing of the INR. Possible adjustment of the dosage of the Vitamin K antagonist.",WARFARIN,11289,160,ANSM,"VITAMIN K ANTAGONISTS",B01AA-001,FLUVASTATIN,41127,69,ANSM,"HMG-COA REDUCTASE INHIBITORS (STATINS)",C10AA
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",CITALOPRAM,2556,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,IMIPRAMINE,5691,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",ESCITALOPRAM,321988,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,IMIPRAMINE,5691,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",FLUOXETINE,4493,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,IMIPRAMINE,5691,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",FLUVOXAMINE,42355,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,IMIPRAMINE,5691,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",PAROXETINE,32937,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,IMIPRAMINE,5691,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",SERTRALINE,36437,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,IMIPRAMINE,5691,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",VORTIOXETINE,1455099,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,IMIPRAMINE,5691,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,AMITRIPTYLINE,704,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,IMIPRAMINE,5691,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,AMOXAPINE,722,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,IMIPRAMINE,5691,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,"CHLORPROMAZINE ",2403,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,IMIPRAMINE,5691,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,CLOMIPRAMINE,2597,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,IMIPRAMINE,5691,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,"CLOZAPINE ",2626,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,IMIPRAMINE,5691,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,DOXEPIN,3638,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,IMIPRAMINE,5691,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,FLUPHENAZINE,4496,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,IMIPRAMINE,5691,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,LOXAPINE,6475,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,IMIPRAMINE,5691,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,MAPROTILINE,6646,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,IMIPRAMINE,5691,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,QUETIAPINE,51272,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,IMIPRAMINE,5691,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,TRIMIPRAMINE,10834,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,IMIPRAMINE,5691,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,AMITRIPTYLINE,704,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,LOXAPINE,6475,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,AMOXAPINE,722,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,LOXAPINE,6475,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,"CHLORPROMAZINE ",2403,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,LOXAPINE,6475,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,CLOMIPRAMINE,2597,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,LOXAPINE,6475,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,"CLOZAPINE ",2626,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,LOXAPINE,6475,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,DOXEPIN,3638,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,LOXAPINE,6475,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,FLUPHENAZINE,4496,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,LOXAPINE,6475,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,IMIPRAMINE,5691,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,LOXAPINE,6475,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,MAPROTILINE,6646,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,LOXAPINE,6475,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,QUETIAPINE,51272,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,LOXAPINE,6475,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,TRIMIPRAMINE,10834,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,LOXAPINE,6475,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,AMITRIPTYLINE,704,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,MAPROTILINE,6646,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,AMOXAPINE,722,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,MAPROTILINE,6646,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,"CHLORPROMAZINE ",2403,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,MAPROTILINE,6646,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,CLOMIPRAMINE,2597,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,MAPROTILINE,6646,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,"CLOZAPINE ",2626,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,MAPROTILINE,6646,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,DOXEPIN,3638,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,MAPROTILINE,6646,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,FLUPHENAZINE,4496,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,MAPROTILINE,6646,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,IMIPRAMINE,5691,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,MAPROTILINE,6646,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,LOXAPINE,6475,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,MAPROTILINE,6646,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,QUETIAPINE,51272,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,MAPROTILINE,6646,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,TRIMIPRAMINE,10834,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,MAPROTILINE,6646,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1640,,NULL,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,ANSM,377-NEUROLEPTICS-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"-with citalopram, domperidone, escitalopram, hydroxyzine and piperaquine","CHLORPROMAZINE ",2403,101,ANSM,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,HALOPERIDOL,5093,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05
1640,,NULL,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,ANSM,377-NEUROLEPTICS-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"-with citalopram, domperidone, escitalopram, hydroxyzine and piperaquine",FLUPHENAZINE,4496,101,ANSM,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,HALOPERIDOL,5093,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05
2208,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,,NULL,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,ANSM,484-SUBSTANCES-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--with citalopram, dromperidone, escitalopram, hydroxyzine, piperaquine","CHLORPROMAZINE ",2403,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,HALOPERIDOL,5093,101,ANSM,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002
2208,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,,NULL,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,ANSM,484-SUBSTANCES-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--with citalopram, dromperidone, escitalopram, hydroxyzine, piperaquine",CITALOPRAM,2556,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,HALOPERIDOL,5093,101,ANSM,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002
2208,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,,NULL,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,ANSM,484-SUBSTANCES-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--with citalopram, dromperidone, escitalopram, hydroxyzine, piperaquine",ESCITALOPRAM,321988,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,HALOPERIDOL,5093,101,ANSM,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002
2208,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,,NULL,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002,ANSM,484-SUBSTANCES-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html,"Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--with citalopram, dromperidone, escitalopram, hydroxyzine, piperaquine",FLUPHENAZINE,4496,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,HALOPERIDOL,5093,101,ANSM,"NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES",N05A-002
2419,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hermorrhage.","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after they are stopped.",APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,IMIPRAMINE,5691,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A
2419,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hermorrhage.","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after they are stopped.",RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,IMIPRAMINE,5691,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A
2419,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hermorrhage.","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after they are stopped.",WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,IMIPRAMINE,5691,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A
2441,,NULL,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,ANSM,"524-TORSADES-DE-POINTES-INDUCING-MEDICATIONS-(EXCEPT-ANTIPARASITICS,-NEUROLEPTICS,-METHADONE).html","Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--for dolasetron, erythromycin, spiramycin, and vincamine, only the forms administered by IV route are affected by this interaction.",CITALOPRAM,2556,144,ANSM,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B,HALOPERIDOL,5093,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05
2441,,NULL,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B,,NULL,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05,ANSM,"524-TORSADES-DE-POINTES-INDUCING-MEDICATIONS-(EXCEPT-ANTIPARASITICS,-NEUROLEPTICS,-METHADONE).html","Increased risk of ventricular arrhythmias, especially of torsades de pointes",Contraindication,"--for dolasetron, erythromycin, spiramycin, and vincamine, only the forms administered by IV route are affected by this interaction.",ESCITALOPRAM,321988,144,ANSM,"TORSADES DE POINTES INDUCING MEDICATIONS (EXCEPT ANTIPARASITICS, NEUROLEPTICS, METHADONE)",C01B,HALOPERIDOL,5093,136,ANSM,"SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES",C01-N05
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,CITALOPRAM,2556,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,PAROXETINE,32937,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,ESCITALOPRAM,321988,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,PAROXETINE,32937,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,FLUOXETINE,4493,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,PAROXETINE,32937,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,FLUVOXAMINE,42355,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,PAROXETINE,32937,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,SERTRALINE,36437,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,PAROXETINE,32937,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",CITALOPRAM,2556,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,MAPROTILINE,6646,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",ESCITALOPRAM,321988,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,MAPROTILINE,6646,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",FLUOXETINE,4493,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,MAPROTILINE,6646,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",FLUVOXAMINE,42355,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,MAPROTILINE,6646,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",PAROXETINE,32937,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,MAPROTILINE,6646,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",SERTRALINE,36437,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,MAPROTILINE,6646,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",VORTIOXETINE,1455099,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,MAPROTILINE,6646,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,AMITRIPTYLINE,704,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,QUETIAPINE,51272,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,AMOXAPINE,722,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,QUETIAPINE,51272,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,"CHLORPROMAZINE ",2403,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,QUETIAPINE,51272,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,CLOMIPRAMINE,2597,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,QUETIAPINE,51272,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,"CLOZAPINE ",2626,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,QUETIAPINE,51272,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,DOXEPIN,3638,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,QUETIAPINE,51272,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,FLUPHENAZINE,4496,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,QUETIAPINE,51272,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,IMIPRAMINE,5691,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,QUETIAPINE,51272,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,LOXAPINE,6475,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,QUETIAPINE,51272,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,MAPROTILINE,6646,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,QUETIAPINE,51272,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,TRIMIPRAMINE,10834,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,QUETIAPINE,51272,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
2417,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,PAROXETINE,32937,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2417,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,PAROXETINE,32937,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2417,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,PAROXETINE,32937,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2419,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hermorrhage.","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after they are stopped.",APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,MILNACIPRAN,588250,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A
2419,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hermorrhage.","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after they are stopped.",RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,MILNACIPRAN,588250,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A
2419,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hermorrhage.","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after they are stopped.",WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,MILNACIPRAN,588250,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",AMITRIPTYLINE,704,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,PAROXETINE,32937,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",AMOXAPINE,722,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,PAROXETINE,32937,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",CLOMIPRAMINE,2597,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,PAROXETINE,32937,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",DOXEPIN,3638,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,PAROXETINE,32937,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",IMIPRAMINE,5691,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,PAROXETINE,32937,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",MAPROTILINE,6646,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,PAROXETINE,32937,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",TRIMIPRAMINE,10834,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,PAROXETINE,32937,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2783,,NULL,"VITAMIN K ANTAGONISTS",B01AA-001,,NULL,"HMG-COA REDUCTASE INHIBITORS (STATINS)",C10AA,ANSM,73-VITAMIN-K-ANTAGONISTS.html,"Increase of the effect of the Vitamin K antagonist and of the risk of hemorrhage","Precaution for use","More frequent testing of the INR. Possible adjustment of the dosage of the Vitamin K antagonist.",WARFARIN,11289,160,ANSM,"VITAMIN K ANTAGONISTS",B01AA-001,PITAVASTATIN,861634,69,ANSM,"HMG-COA REDUCTASE INHIBITORS (STATINS)",C10AA
2783,,NULL,"VITAMIN K ANTAGONISTS",B01AA-001,,NULL,"HMG-COA REDUCTASE INHIBITORS (STATINS)",C10AA,ANSM,73-VITAMIN-K-ANTAGONISTS.html,"Increase of the effect of the Vitamin K antagonist and of the risk of hemorrhage","Precaution for use","More frequent testing of the INR. Possible adjustment of the dosage of the Vitamin K antagonist.",WARFARIN,11289,160,ANSM,"VITAMIN K ANTAGONISTS",B01AA-001,PRAVASTATIN,42463,69,ANSM,"HMG-COA REDUCTASE INHIBITORS (STATINS)",C10AA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,CITALOPRAM,2556,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,SERTRALINE,36437,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,ESCITALOPRAM,321988,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,SERTRALINE,36437,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,FLUOXETINE,4493,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,SERTRALINE,36437,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,FLUVOXAMINE,42355,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,SERTRALINE,36437,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
880,,NULL,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,,NULL,"OTHER HYPONATREMIA INDUCING MEDICATIONS",C03EA,ANSM,274-HYPONATREMIA-INDUCING-MEDICATIONS.html,"Increase of the risk of hyponatremia","Take into account",,PAROXETINE,32937,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA,SERTRALINE,36437,72,ANSM,"HYPONATREMIA INDUCING MEDICATIONS",C03EA
1183,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",CITALOPRAM,2556,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1183,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",ESCITALOPRAM,321988,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1183,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",FLUOXETINE,4493,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1183,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",FLUVOXAMINE,42355,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1183,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",PAROXETINE,32937,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1183,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",SERTRALINE,36437,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1183,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",VORTIOXETINE,1455099,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMITRIPTYLINE,704,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,AMOXAPINE,722,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"CHLORPROMAZINE ",2403,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CITALOPRAM,2556,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,AMITRIPTYLINE,704,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,TRIMIPRAMINE,10834,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,AMOXAPINE,722,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,TRIMIPRAMINE,10834,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,"CHLORPROMAZINE ",2403,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,TRIMIPRAMINE,10834,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,CLOMIPRAMINE,2597,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,TRIMIPRAMINE,10834,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,"CLOZAPINE ",2626,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,TRIMIPRAMINE,10834,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,DOXEPIN,3638,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,TRIMIPRAMINE,10834,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,FLUPHENAZINE,4496,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,TRIMIPRAMINE,10834,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,IMIPRAMINE,5691,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,TRIMIPRAMINE,10834,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,LOXAPINE,6475,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,TRIMIPRAMINE,10834,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,MAPROTILINE,6646,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,TRIMIPRAMINE,10834,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1436,,NULL,"ATROPINIC MEDICATIONS",R06AA,,NULL,"OTHER ATROPINIC MEDICATIONS",R06AA,ANSM,334-ATROPINIC-MEDICATIONS.html,"Addition of the undesirable atropinic effects such as urinary retention, constipation, dry mouth","Take into account",,QUETIAPINE,51272,27,ANSM,"ATROPINIC MEDICATIONS",R06AA,TRIMIPRAMINE,10834,27,ANSM,"ATROPINIC MEDICATIONS",R06AA
1439,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,336-MIXED-ADRENERGIC-SEROTONINERGIC-MEDICATIONS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after it is stopped.",AMITRIPTYLINE,704,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1439,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,336-MIXED-ADRENERGIC-SEROTONINERGIC-MEDICATIONS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after it is stopped.",CLOMIPRAMINE,2597,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1439,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,336-MIXED-ADRENERGIC-SEROTONINERGIC-MEDICATIONS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after it is stopped.",DULOXETINE,72625,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1439,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,336-MIXED-ADRENERGIC-SEROTONINERGIC-MEDICATIONS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after it is stopped.",IMIPRAMINE,5691,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1439,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,336-MIXED-ADRENERGIC-SEROTONINERGIC-MEDICATIONS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after it is stopped.",MILNACIPRAN,588250,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1439,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,336-MIXED-ADRENERGIC-SEROTONINERGIC-MEDICATIONS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after it is stopped.",VENLAFAXINE,39786,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,"RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
2410,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"OTHER ORAL ANTICOAGULANTS",B01A-001,ANSM,52-ORAL-ANTICOAGULANTS.html,"Risk of increase of hemorrhagic events when one oral anticoagulant is replaced with another.","Take into account","Take into account the half-life of the oral anticoagulant and observe, if the situation requires, a delay for clearance before the start of treatment with another. Be sure to inform the patient.",APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
2410,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"OTHER ORAL ANTICOAGULANTS",B01A-001,ANSM,52-ORAL-ANTICOAGULANTS.html,"Risk of increase of hemorrhagic events when one oral anticoagulant is replaced with another.","Take into account","Take into account the half-life of the oral anticoagulant and observe, if the situation requires, a delay for clearance before the start of treatment with another. Be sure to inform the patient.",WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
2417,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,SERTRALINE,36437,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2417,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,SERTRALINE,36437,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2417,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,SERTRALINE,36437,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",AMITRIPTYLINE,704,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,SERTRALINE,36437,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",AMOXAPINE,722,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,SERTRALINE,36437,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",CLOMIPRAMINE,2597,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,SERTRALINE,36437,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",DOXEPIN,3638,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,SERTRALINE,36437,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",IMIPRAMINE,5691,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,SERTRALINE,36437,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",MAPROTILINE,6646,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,SERTRALINE,36437,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",TRIMIPRAMINE,10834,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,SERTRALINE,36437,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2783,,NULL,"VITAMIN K ANTAGONISTS",B01AA-001,,NULL,"HMG-COA REDUCTASE INHIBITORS (STATINS)",C10AA,ANSM,73-VITAMIN-K-ANTAGONISTS.html,"Increase of the effect of the Vitamin K antagonist and of the risk of hemorrhage","Precaution for use","More frequent testing of the INR. Possible adjustment of the dosage of the Vitamin K antagonist.",WARFARIN,11289,160,ANSM,"VITAMIN K ANTAGONISTS",B01AA-001,ROSUVASTATIN,301542,69,ANSM,"HMG-COA REDUCTASE INHIBITORS (STATINS)",C10AA
2783,,NULL,"VITAMIN K ANTAGONISTS",B01AA-001,,NULL,"HMG-COA REDUCTASE INHIBITORS (STATINS)",C10AA,ANSM,73-VITAMIN-K-ANTAGONISTS.html,"Increase of the effect of the Vitamin K antagonist and of the risk of hemorrhage","Precaution for use","More frequent testing of the INR. Possible adjustment of the dosage of the Vitamin K antagonist.",WARFARIN,11289,160,ANSM,"VITAMIN K ANTAGONISTS",B01AA-001,SIMVASTATIN,36567,69,ANSM,"HMG-COA REDUCTASE INHIBITORS (STATINS)",C10AA
876,,NULL,HYPNOTICS,N05-R06,,NULL,"OTHER HYPNOTICS",N05-R06,ANSM,272-HYPNOTICS.html,"Increase of central nervous system depression","Take into account",,ESTAZOLAM,4077,71,ANSM,HYPNOTICS,N05-R06,ZOLPIDEM,39993,71,ANSM,HYPNOTICS,N05-R06
1029,,NULL,"HMG-COA REDUCTASE INHIBITORS (STATINS)",C10AA,,NULL,"VITAMIN K ANTAGONISTS",B01AA-001,ANSM,"289-HMG-COA REDUCTASE INHIBITORS (STATINS).html","Increase of the effect of the vitamin K antagonist and of the risk of hemorrhage","Precaution for use","More frequent testing of the INR Possible adjustment of the dosage of the vitamin K antagonist",ATORVASTATIN,83367,69,ANSM,"HMG-COA REDUCTASE INHIBITORS (STATINS)",C10AA,WARFARIN,11289,160,ANSM,"VITAMIN K ANTAGONISTS",B01AA-001
1029,,NULL,"HMG-COA REDUCTASE INHIBITORS (STATINS)",C10AA,,NULL,"VITAMIN K ANTAGONISTS",B01AA-001,ANSM,"289-HMG-COA REDUCTASE INHIBITORS (STATINS).html","Increase of the effect of the vitamin K antagonist and of the risk of hemorrhage","Precaution for use","More frequent testing of the INR Possible adjustment of the dosage of the vitamin K antagonist",FLUVASTATIN,41127,69,ANSM,"HMG-COA REDUCTASE INHIBITORS (STATINS)",C10AA,WARFARIN,11289,160,ANSM,"VITAMIN K ANTAGONISTS",B01AA-001
1029,,NULL,"HMG-COA REDUCTASE INHIBITORS (STATINS)",C10AA,,NULL,"VITAMIN K ANTAGONISTS",B01AA-001,ANSM,"289-HMG-COA REDUCTASE INHIBITORS (STATINS).html","Increase of the effect of the vitamin K antagonist and of the risk of hemorrhage","Precaution for use","More frequent testing of the INR Possible adjustment of the dosage of the vitamin K antagonist",PITAVASTATIN,861634,69,ANSM,"HMG-COA REDUCTASE INHIBITORS (STATINS)",C10AA,WARFARIN,11289,160,ANSM,"VITAMIN K ANTAGONISTS",B01AA-001
1029,,NULL,"HMG-COA REDUCTASE INHIBITORS (STATINS)",C10AA,,NULL,"VITAMIN K ANTAGONISTS",B01AA-001,ANSM,"289-HMG-COA REDUCTASE INHIBITORS (STATINS).html","Increase of the effect of the vitamin K antagonist and of the risk of hemorrhage","Precaution for use","More frequent testing of the INR Possible adjustment of the dosage of the vitamin K antagonist",PRAVASTATIN,42463,69,ANSM,"HMG-COA REDUCTASE INHIBITORS (STATINS)",C10AA,WARFARIN,11289,160,ANSM,"VITAMIN K ANTAGONISTS",B01AA-001
1029,,NULL,"HMG-COA REDUCTASE INHIBITORS (STATINS)",C10AA,,NULL,"VITAMIN K ANTAGONISTS",B01AA-001,ANSM,"289-HMG-COA REDUCTASE INHIBITORS (STATINS).html","Increase of the effect of the vitamin K antagonist and of the risk of hemorrhage","Precaution for use","More frequent testing of the INR Possible adjustment of the dosage of the vitamin K antagonist",ROSUVASTATIN,301542,69,ANSM,"HMG-COA REDUCTASE INHIBITORS (STATINS)",C10AA,WARFARIN,11289,160,ANSM,"VITAMIN K ANTAGONISTS",B01AA-001
1029,,NULL,"HMG-COA REDUCTASE INHIBITORS (STATINS)",C10AA,,NULL,"VITAMIN K ANTAGONISTS",B01AA-001,ANSM,"289-HMG-COA REDUCTASE INHIBITORS (STATINS).html","Increase of the effect of the vitamin K antagonist and of the risk of hemorrhage","Precaution for use","More frequent testing of the INR Possible adjustment of the dosage of the vitamin K antagonist",SIMVASTATIN,36567,69,ANSM,"HMG-COA REDUCTASE INHIBITORS (STATINS)",C10AA,WARFARIN,11289,160,ANSM,"VITAMIN K ANTAGONISTS",B01AA-001
1183,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",CITALOPRAM,2556,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1183,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",ESCITALOPRAM,321988,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1183,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",FLUOXETINE,4493,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1183,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",FLUVOXAMINE,42355,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1183,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",PAROXETINE,32937,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1183,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",SERTRALINE,36437,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1183,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",VORTIOXETINE,1455099,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",CITALOPRAM,2556,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,TRIMIPRAMINE,10834,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",ESCITALOPRAM,321988,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,TRIMIPRAMINE,10834,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",FLUOXETINE,4493,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,TRIMIPRAMINE,10834,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",FLUVOXAMINE,42355,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,TRIMIPRAMINE,10834,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",PAROXETINE,32937,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,TRIMIPRAMINE,10834,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",SERTRALINE,36437,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,TRIMIPRAMINE,10834,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1184,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,ANSM,294-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",VORTIOXETINE,1455099,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,TRIMIPRAMINE,10834,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,CLOMIPRAMINE,2597,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,DOXEPIN,3638,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,ESCITALOPRAM,321988,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUOXETINE,4493,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUPHENAZINE,4496,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,FLUVOXAMINE,42355,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,"HALOPERIDOL ",5093,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,IMIPRAMINE,5691,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,MAPROTILINE,6646,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,PAROXETINE,32937,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1435,,NULL,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,,NULL,"OTHER MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,ANSM,333-MEDICATIONS-THAT-LOWER-THE-EPILEPTIC-THRESHOLD.html,"Accrued risk of convulsions","Take into account",,SERTRALINE,36437,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002,TRIMIPRAMINE,10834,89,ANSM,"MEDICATIONS THAT LOWER THE EPILEPTIC THRESHOLD",N05AA-002
1439,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,336-MIXED-ADRENERGIC-SEROTONINERGIC-MEDICATIONS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after it is stopped.",AMITRIPTYLINE,704,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1439,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,336-MIXED-ADRENERGIC-SEROTONINERGIC-MEDICATIONS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after it is stopped.",CLOMIPRAMINE,2597,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1439,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,336-MIXED-ADRENERGIC-SEROTONINERGIC-MEDICATIONS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after it is stopped.",DULOXETINE,72625,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1439,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,336-MIXED-ADRENERGIC-SEROTONINERGIC-MEDICATIONS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after it is stopped.",IMIPRAMINE,5691,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1439,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,336-MIXED-ADRENERGIC-SEROTONINERGIC-MEDICATIONS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after it is stopped.",MILNACIPRAN,588250,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1439,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,,NULL,"ORAL ANTICOAGULANTS",B01A-001,ANSM,336-MIXED-ADRENERGIC-SEROTONINERGIC-MEDICATIONS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after it is stopped.",VENLAFAXINE,39786,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",AMITRIPTYLINE,704,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ARIPIPRAZOLE,89013,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CHLORPROMAZINE ",2403,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","CLOZAPINE ",2626,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",DOXEPIN,3638,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",ESTAZOLAM,4077,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLUPHENAZINE,4496,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",FLURAZEPAM,4501,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",HALOPERIDOL,5093,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",LOXAPINE,6475,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MAPROTILINE,6646,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",MIRTAZAPINE,15996,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","OLANZAPINE ",61381,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",PALIPERIDONE,679314,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","QUETIAPINE ",51272,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate","RISPERIDONE ",35636,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
1447,,NULL,"SEDATIVE MEDICATIONS",N04-N05-N06,,NULL,"OTHER SEDATIVE MEDICATIONS",N04-N05-N06,ANSM,339-SEDATIVE-MEDICATIONS.html,"Increase of central nervous center depression. The alteration of alertness can make driving vehicles or using machines dangerous","Not recommended","--with sodium oxybate",TRIMIPRAMINE,10834,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06,ZOLPIDEM,39993,129,ANSM,"SEDATIVE MEDICATIONS",N04-N05-N06
2410,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"OTHER ORAL ANTICOAGULANTS",B01A-001,ANSM,52-ORAL-ANTICOAGULANTS.html,"Risk of increase of hemorrhagic events when one oral anticoagulant is replaced with another.","Take into account","Take into account the half-life of the oral anticoagulant and observe, if the situation requires, a delay for clearance before the start of treatment with another. Be sure to inform the patient.",APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
2410,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"OTHER ORAL ANTICOAGULANTS",B01A-001,ANSM,52-ORAL-ANTICOAGULANTS.html,"Risk of increase of hemorrhagic events when one oral anticoagulant is replaced with another.","Take into account","Take into account the half-life of the oral anticoagulant and observe, if the situation requires, a delay for clearance before the start of treatment with another. Be sure to inform the patient.",RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001
2417,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,VORTIOXETINE,1455099,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2417,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,VORTIOXETINE,1455099,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2417,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hemorrhage","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration with the SSRI and after it is stopped.",WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,VORTIOXETINE,1455099,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2419,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hermorrhage.","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after they are stopped.",APIXABAN,1364430,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,VENLAFAXINE,39786,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A
2419,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hermorrhage.","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after they are stopped.",RIVAROXABAN,1114195,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,VENLAFAXINE,39786,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A
2419,,NULL,"ORAL ANTICOAGULANTS",B01A-001,,NULL,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A,ANSM,52-ORAL-ANTICOAGULANTS.html,"Increase of the risk of hermorrhage.","Precaution for use","Clinical monitoring and, if the situation requires, more frequent testing of the INR. Possible adjustment of the dosage of the oral anticoagulant during the administration of these medications together and after they are stopped.",WARFARIN,11289,112,ANSM,"ORAL ANTICOAGULANTS",B01A-001,VENLAFAXINE,39786,96,ANSM,"MIXED ADRENERGIC-SEROTONINERGIC MEDICATIONS",N06A
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",AMITRIPTYLINE,704,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,VORTIOXETINE,1455099,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",AMOXAPINE,722,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,VORTIOXETINE,1455099,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",CLOMIPRAMINE,2597,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,VORTIOXETINE,1455099,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",DOXEPIN,3638,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,VORTIOXETINE,1455099,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",IMIPRAMINE,5691,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,VORTIOXETINE,1455099,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",MAPROTILINE,6646,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,VORTIOXETINE,1455099,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
2676,,NULL,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,,NULL,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB,ANSM,56-TRICYCLIC-ANTIDEPRESSANTS.html,"Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects","Precaution for use","Increased clinical monitoring and, if necessary, adjustment of the dosage",TRIMIPRAMINE,10834,145,ANSM,"TRICYCLIC ANTIDEPRESSANTS",N06AA-001,VORTIOXETINE,1455099,130,ANSM,"SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",N06AB
